Septic encephalopathy: Inflammation in man and mouse

Neurochemistry International

Volumn 58, Issue 4, 2011, Pages 472-476

  Jacob, Alexander ^a   Brorson, James R ^a   Alexander, Jessy J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Complement system neurotransmitters; Cytokines; Inflammation; Septic encephalopathy

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; ANGIOPOIETIN 2; APOPTOSIS SIGNAL REGULATING KINASE 1; BETA2 INTEGRIN; CD18 ANTIGEN; COMPLEMENT; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 16; INTERLEUKIN 1BETA; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; NEUROTRANSMITTER; NITRIC OXIDE; PROTEIN C JUN; RAS PROTEIN; REACTIVE OXYGEN METABOLITE; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UNINDEXED DRUG;

ARTICLE; BEHAVIOR CHANGE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN DISEASE; CELL DEATH; COMORBIDITY; ENCEPHALITIS; HUMAN; LEUKOCYTE; MINIMAL BRAIN DYSFUNCTION; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; SEPSIS;

ANIMALIA;

EID: 79952106213     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2011.01.004     Document Type: Short Survey

References (93)

1. N.J. Abbott, L. Ronnback, and E. Hansson Astrocyte-endothelial interactions at the blood-brain barrier Nat. Rev. Neurosci. 7 2006 41
2. J.J. Alexander, A. Jacob, P. Cunningham, L. Hensley, and R.J. Quigg TNF is a key mediator of septic encephalopathy acting through its receptor, TNF receptor-1 Neurochem. Int. 52 2008 447
3. J.J. Alexander, A.J. Anderson, S.R. Barnum, B. Stevens, and A.J. Tenner The complement cascade: Yin-Yang in neuroinflammation - neuro-protection and -degeneration J. Neurochem. 107 2008 1169
4. D. Annane Sepsis-associated delirium: the pro and con of C5a blockade Crit. Care 13 2009 135
5. W.S. Bartynski, J.F. Boardman, Z.R. Zeigler, R.K. Shadduck, and J. Lister Posterior reversible encephalopathy syndrome in infection, sepsis, and shock AJNR Am. J. Neuroradiol. 27 2006 2179
6. A. Bengtson, and M. Heideman Anaphylatoxin formation in sepsis Arch. Surg. 123 1988 645
7. E. Boggemeyer, T. Stehle, U.E. Schaible, M. Hahne, D. Vestweber, and M.M. Simon Borrelia burgdorferi upregulates the adhesion molecules E-selectin, P-selectin ICAM-1 and VCAM-1 on mouse endothelioma cells in vitro Cell Adhes. Commun. 2 1994 145
8. M. Bohatschek, A. Werner, and G. Raivich Systemic LPS injection leads to granulocyte influx into normal and injured brain: effects of ICAM-1 deficiency Exp. Neurol. 172 2001 137
9. C.F. Bolton, G.B. Young, and D.W. Zochodne The neurological complications of sepsis Ann. Neurol. 33 1993 94
10. L. Boos, A.J. Szalai, and S.R. Barnum C3a expressed in the central nervous system protects against LPS-induced shock Neurosci. Lett. 387 2005 68
11. 2+]i homeostasis contributes to the toxicity of nitric oxide in cultured hippocampal neurons J. Neurochem. 69 1997 1882
12. 2+ homeostasis in hippocampal neurons J. Neurochem. 68 1997 95
13. J.R. Brorson, P.T. Schumacker, and H. Zhang Nitric oxide acutely inhibits neuronal energy production. The Committees on Neurobiology and Cell Physiology J. Neurosci. 19 1999 147
14. R.C. Brown, A.P. Morris, and O'Neil.F R.G. Tight junction protein expression and barrier properties of immortalized mouse brain microvessel endothelial cells Brain Res. 1130 2007 17
15. D.A. Chesler, and C.S. Reiss The role of IFN-gamma in immune responses to viral infections of the central nervous system Cytokine Growth Factor Rev. 13 2002 441
16. M. Ckert-Schluter, D. Schluter, H. Hof, O.D. Wiestler, and H. Lassmann Differential expression of ICAM-1, VCAM-1 and their ligands LFA-1, Mac-1, CD43 VLA-4, and MHC class II antigens in murine Toxoplasma encephalitis: a light microscopic and ultrastructural immunohistochemical study J. Neuropathol. Exp. Neurol. 53 1994 457
17. C.M. Comim, L.C. Constantino, T. Barichello, E.L. Streck, J. Quevedo, and F. Dal-Pizzol Cognitive impairment in the septic brain Curr. Neurovasc. Res. 6 2009 194
18. J. Cunneen, and M. Cartwright The puzzle of sepsis: fitting the pieces of the inflammatory response with treatment AACN. Clin. Issues 15 2004 18
19. M.R. Daha, K.C. van, and Roos.F A. Compliments from complement: a fourth pathway of complement activation? Nephrol. Dial. Transplant. 21 2006 3374
20. D.C. Davies Blood-brain barrier breakdown in septic encephalopathy and brain tumours J. Anat. 200 2002 639
21. H. Davson, B.V. Zlokovic, L. Rakic, and M.B. Segal An Introduction to the Blood-Brain Barrier 1993 Macmillan London
22. M.R. Del, H.H. Thaw, J. Bjork, M. Planker, and K.E. Arfors Free radicals as mediators of tissue injury Acta Physiol. Scand. Suppl. 492 1980 43
23. A.F. Ducruet, B.E. Zacharia, Z.L. Hickman, B.T. Grobelny, M.L. Yeh, S.A. Sosunov, and E.S. Connolly Jr. The complement cascade as a therapeutic target in intracerebral hemorrhage Exp. Neurol. 219 2009 398
24. M. Ebersoldt, T. Sharshar, and D. Annane Sepsis-associated delirium Intensive Care Med. 33 2007 941
25. L.A. Eidelman, D. Putterman, C. Putterman, and C.L. Sprung The spectrum of septic encephalopathy. Definitions, etiologies, and mortalities JAMA 275 1996 470
26. I.J. Elenkov Neurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-being Neurochem. Int. 52 2008 40
27. I.J. Elenkov, R.L. Wilder, G.P. Chrousos, and Vizi.F E.S. The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system Pharmacol. Rev. 52 2000 595
28. F. Esen, T. Erdem, D. Aktan, M. Orhan, M. Kaya, H. Eraksoy, N. Cakar, and L. Telci Effect of magnesium sulfate administration on blood-brain barrier in a rat model of intraperitoneal sepsis: a randomized controlled experimental study Crit. Care 9 2005 R18 R23
29. M.A. Flierl, P.F. Stahel, D. Rittirsch, M. Huber-Lang, A.D. Niederbichler, L.M. Hoesel, B.M. Touban, S.J. Morgan, W.R. Smith, P.A. Ward, and K. Ipaktchi Inhibition of complement C5a prevents breakdown of the blood-brain barrier and pituitary dysfunction in experimental sepsis Crit. Care 13 2009 R12
30. H.R. Freund, M. Muggia-Sullam, J. Peiser, and E. Melamed Brain neurotransmitter profile is deranged during sepsis and septic encephalopathy in the rat J. Surg. Res. 38 1985 267
31. J.E. Fugate, D.O. Claassen, H.J. Cloft, D.F. Kallmes, O.S. Kozak, and A.A. Rabinstein Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings Mayo Clin. Proc. 85 2010 427
32. A. Gardenfors, F. Nilsson, G. Skagerberg, U. Ungerstedt, and C.H. Nordstrom Cerebral physiological and biochemical changes during vasogenic brain oedema induced by intrathecal injection of bacterial lipopolysaccharides in piglets Acta Neurochir. (Wien.) 144 2002 601
33. M.A. Gimenez, J.E. Sim, and J.H. Russell TNFR1-dependent VCAM-1 expression by astrocytes exposes the CNS to destructive inflammation J. Neuroimmunol. 151 2004 116
34. O. Gotze, and H.J. Muller-Eberhard The alternative pathway of complement activation Adv. Immunol. 24 1976 1
35. R.F. Guo, N.C. Riedemann, and Ward.F P.A. Role of C5a-C5aR interaction in sepsis Shock 21 2004 1
36. S. Hofer, C. Bopp, C. Hoerner, K. Plaschke, R.M. Faden, E. Martin, H.J. Bardenheuer, and M.A. Weigand Injury of the blood brain barrier and up-regulation of icam-1 in polymicrobial sepsis J. Surg. Res. 146 2008 276
37. R.O. Hopkins, and J.C. Jackson Long-term neurocognitive function after critical illness Chest 130 2006 869
38. R.O. Hopkins, and J.C. Jackson Assessing neurocognitive outcomes after critical illness: are delirium and long-term cognitive impairments related? Curr. Opin. Crit. Care 12 2006 388
39. R.O. Hopkins, E.W. Ely, and J.C. Jackson The role of future longitudinal studies in ICU survivors: understanding determinants and pathophysiology of brain dysfunction Curr. Opin. Crit. Care 13 2007 497
40. M.S. Huber-Lang, E.M. Younkin, J.V. Sarma, S.R. McGuire, K.T. Lu, R.F. Guo, V.A. Padgaonkar, J.T. Curnutte, R. Erickson, and Ward.F P.A. Complement-induced impairment of innate immunity during sepsis J. Immunol. 169 2002 3223
41. A. Jacob, L.K. Hensley, B.D. Safratowich, R.J. Quigg, and J.J. Alexander The role of the complement cascade in endotoxin-induced septic encephalopathy Lab. Invest. 87 2007 1186
42. A. Jacob, B. Hack, E. Chiang, J.G. Garcia, R.J. Quigg, and J.J. Alexander C5a alters blood-brain barrier integrity in experimental lupus FASEB J. 2010
43. B. Jeppsson, H.R. Freund, Z. Gimmon, J.H. James, M.F. von Meyenfeldt, and J.E. Fischer Blood-brain barrier derangement in sepsis: cause of septic encephalopathy? Am. J. Surg. 141 1981 136
44. R.B. Johnston Jr. The complement system in host defense and inflammation: the cutting edges of a double edged sword Pediatr. Infect. Dis. J. 12 1993 933
45. Y. Kadoi, and F. Goto Selective inducible nitric oxide inhibition can restore hemodynamics, but does not improve neurological dysfunction in experimentally induced septic shock in rats Anesth. Analg. 99 2004 212
46. R.J. Komotar, R.M. Starke, E.J. Arias, M.C. Garrett, M.L. Otten, M.B. Merkow, B. Hassid, J. Mocco, M.E. Sughrue, G.H. Kim, W.J. Mack, A.F. Ducruet, and E.S. Connolly The complement cascade: new avenues in stroke therapy Curr. Vasc. Pharmacol. 7 2009 287
47. W.L. Kuo, M. Abe, J. Rhee, E.M. Eves, S.A. McCarthy, M. Yan, D.J. Templeton, M. McMahon, and M.R. Rosner Raf, but not MEK or ERK, is sufficient for differentiation of hippocampal neuronal cells Mol. Cell Biol. 16 1996 1458
48. J. Liu, and A. Lin Role of JNK activation in apoptosis: a double-edged sword Cell Res. 15 2005 36
49. J. Liu, Y. Minemoto, and Lin.F A. c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis Mol. Cell Biol. 24 2004 10844
50. L. McNally, Z. Bhagwagar, and J. Hannestad Inflammation, glutamate, and glia in depression: a literature review CNS. Spectr. 13 2008 501
51. J.E. Merrill, and E.N. Benveniste Cytokines in inflammatory brain lesions: helpful and harmful Trends Neurosci. 19 1996 331
52. J.E. Merrill, and S.P. Murphy Inflammatory events at the blood brain barrier: regulation of adhesion molecules, cytokines, and chemokines by reactive nitrogen and oxygen species Brain Behav. Immun. 11 1997 245
53. J. Mocco, W.J. Mack, A.F. Ducruet, S.A. Sosunov, M.E. Sughrue, B.G. Hassid, M.N. Nair, I. Laufer, R.J. Komotar, M. Claire, H. Holland, D.J. Pinsky, and E.S. Connolly Jr. Complement component C3 mediates inflammatory injury following focal cerebral ischemia Circ. Res. 99 2006 209
54. H.J. Muller-Eberhard The membrane attack complex of complement Annu. Rev. Immunol. 4 1986 503
55. H.J. Muller-Eberhard Molecular organization and function of the complement system Annu. Rev. Biochem. 57 1988 321
56. H.J. Muller-Eberhard, and R.D. Schreiber Molecular biology and chemistry of the alternative pathway of complement Adv. Immunol. 29 1980 1
57. T. Nishioku, S. Dohgu, F. Takata, T. Eto, N. Ishikawa, K.B. Kodama, S. Nakagawa, A. Yamauchi, and Y. Kataoka Detachment of brain pericytes from the basal lamina is involved in disruption of the blood-brain barrier caused by lipopolysaccharide-induced sepsis in mice Cell Mol. Neurobiol. 29 2009 309
58. M.U. Norman, W.G. James, and M.J. Hickey Differential roles of ICAM-1 and VCAM-1 in leukocyte-endothelial cell interactions in skin and brain of MRL/faslpr mice J. Leukoc. Biol. 2008
59. N. Oppenheimer-Marks, L.S. Davis, D.T. Bogue, J. Ramberg, and P.E. Lipsky Differential utilization of ICAM-1 and VCAM-1 during the adhesion and transendothelial migration of human T lymphocytes J. Immunol. 147 1991 2913
60. W. Pan, W.A. Banks, and A.J. Kastin Blood-brain barrier permeability to ebiratide and TNF in acute spinal cord injury Exp. Neurol. 146 1997 367
61. M.C. Papadopoulos, D.C. Davies, R.F. Moss, D. Tighe, and E.D. Bennett Pathophysiology of septic encephalopathy: a review Crit. Care Med. 28 2000 3019
62. P. Peduzzi, C. Shatney, J. Sheagren, and C. Sprung Predictors of bacteremia and gram-negative bacteremia in patients with sepsis. The Veterans Affairs Systemic Sepsis Cooperative Study Group Arch. Intern. Med. 152 1992 529
63. O. Piazza, S. Cotena, R.E. De, F. Caranci, and R. Tufano Sepsis associated encephalopathy studied by MRI and cerebral spinal fluid S100B measurement Neurochem. Res. 34 2009 1289
64. B. Poch, F. Gansauge, B. Rau, U. Wittel, S. Gansauge, A.K. Nussler, M. Schoenberg, and H.G. Beger The role of polymorphonuclear leukocytes and oxygen-derived free radicals in experimental acute pancreatitis: mediators of local destruction and activators of inflammation FEBS Lett. 461 1999 268
65. G. Pryce, D. Male, I. Campbell, and J. Greenwood Factors controlling T-cell migration across rat cerebral endothelium in vitro J. Neuroimmunol. 75 1997 84
66. P. Pytel, and J.J. Alexander Pathogenesis of septic encephalopathy Curr. Opin. Neurol. 22 2009 283
67. W. Risau, B. Engelhardt, and H. Wekerle Immune function of the blood-brain barrier: incomplete presentation of protein (auto-)antigens by rat brain microvascular endothelium in vitro J. Cell Biol. 110 1990 1757
68. B. Rosengarten, M. Hecht, D. Auch, H.A. Ghofrani, R.T. Schermuly, F. Grimminger, and M. Kaps Microcirculatory dysfunction in the brain precedes changes in evoked potentials in endotoxin-induced sepsis syndrome in rats Cerebrovasc. Dis. 23 2007 140
69. P.P. Roux, and J. Blenis ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions Microbiol. Mol. Biol. Rev. 68 2004 320
70. H. Rus, C. Cudrici, S. David, and F. Niculescu The complement system in central nervous system diseases Autoimmunity 39 2006 395
71. P. Sarantos, A. Abouhamze, R. Chakrabarti, and W.W. Souba Glucocorticoids regulate intestinal glutamine synthetase gene expression in endotoxemia Arch. Surg. 129 1994 59
72. A. Semmler, S. Hermann, F. Mormann, M. Weberpals, S.A. Paxian, T. Okulla, M. Schafers, M.P. Kummer, T. Klockgether, and M.T. Heneka Sepsis causes neuroinflammation and concomitant decrease of cerebral metabolism J. Neuroinflamm. 5 2008 38
73. T. Sharshar, N.S. Hopkinson, D. Orlikowski, and D. Annane Science review: the brain in sepsis-culprit and victim Crit. Care 9 2005 37
74. I. Shimizu, N. Adachi, K. Liu, B. Lei, T. Nagaro, and Arai.F T. Sepsis facilitates brain serotonin activity and impairs learning ability in rats Brain Res. 830 1999 94
75. G. Smedegard, L.X. Cui, and T.E. Hugli Endotoxin-induced shock in the rat. A role for C5a Am. J. Pathol. 135 1989 489
76. L. Soane, H.J. Cho, F. Niculescu, H. Rus, and Shin.F M.L. C5b-9 terminal complement complex protects oligodendrocytes from death by regulating Bad through phosphatidylinositol 3-kinase/Akt pathway J. Immunol. 167 2001 2305
77. C.L. Sprung, P.N. Peduzzi, C.H. Shatney, R.M. Schein, M.F. Wilson, J.N. Sheagren, and L.B. Hinshaw Impact of encephalopathy on mortality in the sepsis syndrome. The Veterans Administration Systemic Sepsis Cooperative Crit Care Med. 18 1990 801
78. N. Stocchetti Brain and sepsis: functional impairment, structural damage, and markers Anesth. Analg. 101 2005 1463
79. S. Stove, T. Welte, T.O. Wagner, A. Kola, A. Klos, W. Bautsch, and Kohl.F J. Circulating complement proteins in patients with sepsis or systemic inflammatory response syndrome Clin. Diagn. Lab Immunol. 3 1996 175
80. J.S. Straver, R.W. Keunen, C.J. Stam, D.L. Tavy, G.R. de Ruiter, S.J. Smith, L.G. Thijs, R.G. Schellens, and G. Gielen Nonlinear analysis of EEG in septic encephalopathy Neurol. Res. 20 1998 100
81. E.L. Streck, C.M. Comim, T. Barichello, and J. Quevedo The septic brain Neurochem. Res. 33 2008 2171
82. H.Z. Toklu, M.K. Uysal, L. Kabasakal, S. Sirvanci, F. Ercan, and Kaya.F M. The effects of riluzole on neurological, brain biochemical, and histological changes in early and late term of sepsis in rats J. Surg. Res. 152 2009 238
83. N. Tsao, H.P. Hsu, C.M. Wu, C.C. Liu, and Lei.F H.Y. Tumour necrosis factor-alpha causes an increase in blood-brain barrier permeability during sepsis J. Med. Microbiol. 50 2001 812
84. T. van der Pol, S.M. Coyle, K. Barbosa, C.C. Braxton, and S.F. Lowry Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia J. Clin. Invest. 97 1996 713
85. M. Vega-Ostertag, K. Casper, R. Swerlick, D. Ferrara, E.N. Harris, and S.S. Pierangeli Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies Arthritis Rheum. 52 2005 1545
86. K. Voigt, A. Kontush, H.J. Stuerenburg, D. Muench-Harrach, H.C. Hansen, and K. Kunze Decreased plasma and cerebrospinal fluid ascorbate levels in patients with septic encephalopathy Free Radic. Res. 36 2002 735
87. P.A. Ward Sepsis, apoptosis and complement Biochem. Pharmacol. 76 2008 1383
88. P.A. Ward Role of the complement in experimental sepsis J. Leukoc. Biol. 83 2008 467
89. J.X. Wilson, and M. Dragan Sepsis inhibits recycling and glutamate-stimulated export of ascorbate by astrocytes Free Radic. Biol. Med. 39 2005 990
90. J.X. Wilson, and G.B. Young Progress in clinical neurosciences: sepsis-associated encephalopathy: evolving concepts Can. J. Neurol. Sci. 30 2003 98
91. T.R. Winder, G.Y. Minuk, E.J. Sargeant, and T.P. Seland gamma-Aminobutyric acid (GABA) and sepsis-related encephalopathy Can. J. Neurol. Sci. 15 1988 23
92. G.B. Young, C.F. Bolton, T.W. Austin, Y.M. Archibald, J. Gonder, and G.A. Wells The encephalopathy associated with septic illness Clin. Invest. Med. 13 1990 297
93. G.B. Young, C.F. Bolton, Y.M. Archibald, T.W. Austin, and G.A. Wells The electroencephalogram in sepsis-associated encephalopathy J. Clin. Neurophysiol. 9 1992 145